pradefovir mesylate

DRUG2 trials

Sponsors

Bausch Health Americas, Inc.

Conditions

Hepatitis B, Chronic

Phase 2

Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B

CompletedNCT00230503

Bausch Health Americas, Inc.Hepatitis B, Chronic

Start: 2004-06-30End: 2006-12-31Target: 220Updated: 2012-06-22

Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201

TerminatedNCT00230490

Bausch Health Americas, Inc.Hepatitis B, Chronic

Start: 2005-06-30End: 2007-05-31Target: 150Updated: 2019-11-29

Related Papers

Pradefovir Treatment in Patients With Chronic Hepatitis B: Week 24 Results From a Multicenter, Double-Blind, Randomized, Noninferiority, Phase 2 Trial

Clinical Infectious Diseases2021-09-0613 citations